Follow-on Biologics |
||
|
FACTBOX-Winners, losers in U.S. Senate health bill
Winners, losers in U.S. Senate health bill
Senate health bill helps chiropractors, biologic drugmakers but whacks insurance executives
FDA Expert Panel Declines to Endorse New Influenza Vaccine
Senate Healthcare Bill Preserves Biologics Exclusivity, Drugmaker Fee
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) [Press Release]
Pfizer Receives FDA Approval For Geodon (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults [Press Release]
FDA Approves Intravenous Formulation Of Pfizer s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension [Press Release]
Peter Orszag: Bills offer clear path to better health care
We can deliver health reform
FDA Advisory Committee Finds Data Support the Claim That SPIRIVA HandiHaler Reduces COPD Exacerbations [Press Release]
VisEn Launches New OsteoSense(R) 800 and VivoTag(R) 800 Fluorescence Molecular Imaging Agents [Press Release]
Research and Markets: Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009 [Press Release]
Fact or Fiction: Generic Drugs Are Bad for You
Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research Exec to Retire; More... - Pharmaceutical Technology [Press Release] 1368 Results |
||
Sign up for BIO SmartBrief
Latest Blog Postsview more
Head Lice Treatment
Science Blog
Head Lice Treatment
Science Blog
Melanoma News Database MMMP
Science Blog
Melanoma News Database MMMP
Science Blog
Companies in the news
- Actelion Ltd
- Affymax Inc.
- AstraZeneca PLC
- Bayer Schering Pharma
- Biogen IDEC Inc.
- Genentech
- Genzyme
- GlaxoSmithKline plc
- Merck & Co.
- Nabi Biopharmaceuticals
- Pfizer
- Regeneron Pharmaceutical
- Vivus Inc.
- Watson Pharmaceuticals
- Wockhardt Limited
